Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Rigby

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology. Supplement|September 18, 1997
Viruses in the etiopathogenesis of Sjögren's syndromeP J Venables, S P Rigby
Rheumatology (Oxford, England)|May 27, 2008
Comment on: Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyJ Bateman, R Penfold, S P Rigby
Current Pharmaceutical Design|August 5, 2008
Engineering silica particles as oral drug delivery vehiclesS P Rigby, M Fairhead, C F van der Walle
The Journal of Rheumatology|May 23, 1998
A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndromeE J Price, S P Rigby, U Clancy, et al.
Arthritis and Rheumatism|September 1, 1996
Absence of HTLV-1 tax in Sjögren's syndromeS P Rigby, S P Cooke, D Weerasinghe, et al.
Arthritis and Rheumatism|November 19, 1997
Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren's syndromeS P Rigby, D J Griffiths, R A Weiss, et al.
Annales De Medecine Interne|August 9, 2001
Viral studies in rheumatic diseaseS P Cooke, S P Rigby, D J Griffiths, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 21, 2013
The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetesJ Rosenstock, S P Rigby, D M Ford, et al.
Rheumatology (Oxford, England)|June 23, 1999
Oral methotrexate: the hazard of different tablet strengthsJ M Schott, S P Rigby, J D McNally, et al.
Physical Review. E|February 13, 2016
Statistics of highly heterogeneous flow fields confined to three-dimensional random porous mediaC Jin, P A Langston, G E Pavlovskaya, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology. Supplement|September 18, 1997
Viruses in the etiopathogenesis of Sjögren's syndromeP J Venables, S P Rigby
Rheumatology (Oxford, England)|May 27, 2008
Comment on: Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyJ Bateman, R Penfold, S P Rigby
Current Pharmaceutical Design|August 5, 2008
Engineering silica particles as oral drug delivery vehiclesS P Rigby, M Fairhead, C F van der Walle
The Journal of Rheumatology|May 23, 1998
A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndromeE J Price, S P Rigby, U Clancy, et al.
Arthritis and Rheumatism|September 1, 1996
Absence of HTLV-1 tax in Sjögren's syndromeS P Rigby, S P Cooke, D Weerasinghe, et al.
Arthritis and Rheumatism|November 19, 1997
Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren's syndromeS P Rigby, D J Griffiths, R A Weiss, et al.
Annales De Medecine Interne|August 9, 2001
Viral studies in rheumatic diseaseS P Cooke, S P Rigby, D J Griffiths, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 21, 2013
The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetesJ Rosenstock, S P Rigby, D M Ford, et al.
Rheumatology (Oxford, England)|June 23, 1999
Oral methotrexate: the hazard of different tablet strengthsJ M Schott, S P Rigby, J D McNally, et al.
Physical Review. E|February 13, 2016
Statistics of highly heterogeneous flow fields confined to three-dimensional random porous mediaC Jin, P A Langston, G E Pavlovskaya, et al.
Pageof 2